Now Enrolling Children Ages 6–17 with Migraine Attacks

We’re enrolling children (ages 6–17) experiencing migraine headaches for a clinical research study.
This study is evaluating an investigational medication as a potential treatment for preventing migraine attacks in children.

Eligibility Criteria

Your child may qualify if they:

• Are between 6 and 17 years old

• Have been diagnosed with migraine headaches for at least 6 months

• Experience 4–14 migraine headache days per month

What Participants Receive

Qualified participants will receive:

• Care by a team of experienced doctors and nurses

• Study-related visits, assessments, and investigational medication at no cost

• Compensation for time and travel

• No health insurance required

Benefits of Participation

• Study care at no cost

• Dedicated medical staff

• Help advance pediatric migraine treatment

• Join a local research study